Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-12 Sale | 2025-03-13 8:00 pm | Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director | 2,491 | $99.64 | $248,203 | 27,812 (Direct) | View |
| 2024-12-12 Sale | 2024-12-16 8:00 pm | Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director | 10,500 | $124.84 | $1,310,820 | 22,840 (Direct) | View |
| 2024-12-05 Sale | 2024-12-06 8:00 pm | Sarepta Therapeutics Inc. | SRPT | Boor Kathryn Jean Director | 1,636 | $125.55 | $205,400 | 5,880 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-12 Exercise | 2025-03-13 8:00 pm | 2016-06-02 2025-06-02 | Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director | 9,746 | $0 | 27,812 (Direct) | View |
| 2025-03-12 Exercise | 2025-03-13 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director | 9,746 | $25.18 | 27,812 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | Connelly Deirdre P Director | 7,175 | $0 | 10,017 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | Boor Kathryn Jean Director | 7,175 | $0 | 13,055 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | Chambers Michael Andrew Director | 7,175 | $0 | 299,486 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel | 24,920 | $0 | 37,754 (Direct) | View |
| 2025-03-10 Tax Withholding | 2025-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel | 491 | $100.13 | 37,754 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 5,500 | $0 | 79,256 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 24,920 | $0 | 79,256 (Direct) | View |
| 2025-03-10 Tax Withholding | 2025-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 3,941 | $100.13 | 79,256 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director | 7,175 | $0 | 30,015 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | Mayo Stephen Director | 7,175 | $0 | 13,796 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 24,920 | $0 | 49,144 (Direct) | View |
| 2025-03-10 Tax Withholding | 2025-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 523 | $100.13 | 49,144 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 5,500 | $0 | 101,275 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 24,920 | $0 | 101,275 (Direct) | View |
| 2025-03-10 Tax Withholding | 2025-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 3,463 | $100.13 | 101,275 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer | 5,500 | $0 | 54,846 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer | 24,920 | $0 | 54,846 (Direct) | View |
| 2025-03-10 Tax Withholding | 2025-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer | 3,733 | $100.13 | 54,846 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 7,175 | $0 | 3,188,863 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director | 7,175 | $0 | 41,114 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director | 7,175 | $0 | 208,268 (Direct) | View |
| 2025-03-06 Exercise | 2025-03-10 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 17,500 | $0 | 52,777 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-10 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 9,679 | $103.7 | 52,777 (Direct) | View |
| 2025-03-06 Exercise | 2025-03-10 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 17,500 | $0 | 74,318 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-10 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 8,504 | $103.7 | 74,318 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-10 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel | 1,478 | $103.7 | 11,847 (Direct) | View |
| 2025-03-06 Exercise | 2025-03-10 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer | 17,500 | $0 | 28,159 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-10 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer | 9,162 | $103.7 | 28,159 (Direct) | View |
| 2025-03-06 Exercise | 2025-03-10 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 17,500 | $0 | 24,747 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-10 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 9,035 | $103.7 | 24,747 (Direct) | View |
| 2025-03-04 Tax Withholding | 2025-03-06 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel | 584 | $101.34 | 13,325 (Direct) | View |
| 2025-03-04 Tax Withholding | 2025-03-06 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 514 | $101.34 | 16,282 (Direct) | View |
| 2025-03-04 Tax Withholding | 2025-03-06 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer | 1,685 | $101.34 | 19,821 (Direct) | View |
| 2025-03-04 Tax Withholding | 2025-03-06 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 1,370 | $101.34 | 44,956 (Direct) | View |
| 2025-03-04 Tax Withholding | 2025-03-06 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 1,704 | $101.34 | 65,322 (Direct) | View |
| 2025-03-03 Tax Withholding | 2025-03-04 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer | 711 | $103.77 | 21,506 (Direct) | View |
| 2025-03-03 Tax Withholding | 2025-03-04 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 719 | $103.77 | 16,796 (Direct) | View |
| 2025-03-03 Tax Withholding | 2025-03-04 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 557 | $103.77 | 46,326 (Direct) | View |
| 2025-03-03 Tax Withholding | 2025-03-04 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 715 | $103.77 | 67,026 (Direct) | View |
| 2025-03-03 Tax Withholding | 2025-03-04 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel | 391 | $103.77 | 13,621 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 3,500 | $0 | 17,500 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 3,500 | $0 | 17,500 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer | 3,500 | $0 | 17,500 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 3,500 | $0 | 17,500 (Direct) | View |
| 2025-01-29 Exercise | 2025-01-31 8:30 pm | 2016-01-30 2025-01-30 | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 15,800 | $0 | 46,883 (Direct) | View |
| 2025-01-29 Exercise | 2025-01-31 8:30 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 15,800 | $12 | 46,883 (Direct) | View |
| 2025-01-29 Tax Withholding | 2025-01-31 8:30 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 2,613 | $117.51 | 46,883 (Direct) | View |
| 2024-12-27 Gift | 2024-12-30 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 250 | $0 | 33,696 (Direct) | View |
| 2024-12-12 Exercise | 2024-12-16 8:00 pm | 2017-02-28 2026-02-28 | Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director | 10,500 | $0 | 22,840 (Direct) | View |
| 2024-12-12 Exercise | 2024-12-16 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director | 10,500 | $13.71 | 22,840 (Direct) | View |
| 2024-11-26 Option Award | 2024-11-29 8:15 pm | 2025-11-26 2034-11-26 | Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel | 6,000 | $0 | 17,817 (Direct) | View |
Ownership | 2024-11-29 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel | 0 | $0 | 39,916 (Direct) | View |
| 2024-11-18 Tax Withholding | 2024-11-20 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 4,558 | $102.89 | 67,630 (Direct) | View |